Pembrolizumab is a type of medication known as an immunotherapy. It works by helping your immune system fight cancer cells. In this trial, pembrolizumab is being tested to see if it can help improve the treatment of ovarian cancer when used with other medications.

Paclitaxel is a chemotherapy drug that is used to stop the growth of cancer cells. It works by interfering with the way cells divide, which can slow down or stop the spread of cancer. In this study, paclitaxel is used in combination with other treatments to see if it can be more effective against ovarian cancer.

Bevacizumab is a medication that works by blocking the growth of new blood vessels that tumors need to grow. By cutting off the blood supply, bevacizumab can help slow down the growth of cancer. In this trial, it is used alongside other treatments to see if it can improve outcomes for patients with ovarian cancer.

Ovarian carcinoma – Ovarian carcinoma is a type of cancer that begins in the ovaries, which are the reproductive glands found in women. It often starts on the surface of the ovary and can spread to other parts of the pelvis and abdomen. The disease progresses through stages, beginning with localized growth and potentially advancing to widespread metastasis. Symptoms may include abdominal bloating, pelvic pain, and changes in bowel habits. As the disease advances, it can lead to fluid accumulation in the abdomen and other systemic symptoms. The progression is typically monitored through imaging and clinical evaluation.

Fallopian tube carcinoma – Fallopian tube carcinoma is a rare cancer that originates in the fallopian tubes, which connect the ovaries to the uterus. It often presents with symptoms such as pelvic pain, abnormal vaginal bleeding, and a pelvic mass. The disease can spread to nearby organs and tissues, including the ovaries and peritoneum. As it progresses, it may cause more generalized symptoms like abdominal swelling and discomfort. The cancer is staged based on its spread, with early stages confined to the tubes and later stages involving distant metastasis. Monitoring involves regular imaging and physical examinations.

Primary peritoneal carcinoma – Primary peritoneal carcinoma is a cancer that arises from the peritoneum, the lining of the abdominal cavity. It shares many similarities with ovarian cancer, including its symptoms and progression. The disease often presents with abdominal pain, bloating, and changes in bowel habits. As it advances, it can lead to fluid buildup in the abdomen and spread to other organs. The progression is categorized into stages, with early stages being localized and later stages involving widespread dissemination. Regular monitoring through imaging and clinical assessments is essential to track its progression.